`

BenevolentAI

Biotechnology Research

Specialities :
Artificial intelligence
Drug development
Scientific innovation
Machine learning
Deep learning

+4

Last Updated: November 20, 2025
Revenue
$12.73M
funding-icon Total Funding
$292.00M
Size
51 - 200

Frequently Asked Questions About BenevolentAI

What does Benevolentai do?+

BenevolentAI is a pioneer and leader in applying advanced explainable AI to drug discovery and development. In a world where the drug development failure rate still exceeds 90% and thousands of complex diseases lack effective treatment, our technology can increase the probability of success and reduce timelines. Our proprietary Benevolent PlatformTM is one of the industrys most established and validated AI drug discovery technologies. In 2020, it took our scientists just 48 hours to identify baricitinib as a potential treatment for COVID-19. This became the first AI-identified drug indication to receive full FDA approval. Our expertise in target identification and...

What are Benevolentai's specialties? +

Artificial intelligence,drug development,scientific innovation,machine learning,deep learning,big data,pharmaceutical,biopharma,and drug discovery

What is Benevolentai's industry? +

Benevolentai operates in the Biotechnology research industry.

What is Benevolentai's revenue? +

Benevolentai's revenue is $12.73m

What is Benevolentai's company size? +

Benevolentai has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.